GEHCGE HealthCare

1. Sep 22, 2026On September 22, 2026, the Board of Directors (the “Board”) of GE HealthCare Technologies Inc. (the “Company”) appointed Pascal Desroches to serve as a director of the Company, effective January 4, 2027.Director or officer change · Form 8-K
2. Aug 18, 2026On August 13, 2026, the Board of Directors (the “Board”) of GE HealthCare Technologies Inc. (“GE HealthCare”) appointed William K. Grogan as Chief Financial Officer, effective September 14, 2026.Director or officer change · Form 8-K
3. Jul 29, 2026Recast Unaudited Historical Financial Information Reflecting the Company’s New Reportable Segment Structure.Regulation FD disclosure · press release
4. Jul 23, 2026Departure of Directors or Certain Officers On July 21, 2026, James K. (Jay) Saccaro notified GE HealthCare that he will resign as Chief Financial Officer for a role outside of the medical technology industry.Earnings release · Form 8-K
5. May 11, 2026Effective as of May 7, 2026, the Company’s Board of Directors (the "Board") appointed Rodney F. Hochman as the Board's independent lead director and appointed Anne T. Madden as chairperson of the Nominating and Governance Committee of the Board.Shareholder vote results · Form 8-K
6. Mar 17, 2026On March 13, 2026, the Board of Directors (the “Board”) of GE HealthCare Technologies Inc. (the “Company”) appointed Kevin A. Lobo to serve as a director of the Company, effective immediately.Director or officer change · Form 8-K
7. Feb 27, 2026On February 26, 2026, GE HealthCare Technologies Inc. (the “Company”) entered into a 364-Day Revolving Credit Agreement (the “New Revolving Credit Agreement”) among the Company, JPMorgan Chase Bank, N.A., as administrative agent, and the lenders named therein, which provides for a 364-day senior unsecured revolving …Material agreement entered · Form 8-K
8. Dec 15, 2025On December 12, 2025, GE HealthCare Technologies Inc. (the “Company”) entered into a three-year senior unsecured term loan credit facility (the “Term Loan Credit Agreement”) among the Company, JPMorgan Chase Bank, N.A., as administrative agent, and the lenders named therein.Material agreement entered · Form 8-K
9. Dec 2, 2025On December 1, 2025, GE HealthCare Technologies Inc. (the “Company”) commenced and priced an underwritten offering (the “Offering”) of $600,000,000 aggregate principal amount of 4.150% Notes due December 15, 2028 (the “2028 Notes”) and $650,000,000 aggregate principal amount of 4.950% Notes due December 15, 2035 (the …Other event · Form 8-K

Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.